Corvus Pharmaceuticals (CRVS) Earnings Date & Reports

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

CRVS is expected to report earnings to fall 80.67% to -11 cents per share on March 07

Corvus Pharmaceuticals CRVS Stock Earnings Reports

Q4'24

Est.

$-0.12

Q3'24

Missed

by $0.49

Q2'24

Beat

by $0.05

Q1'24

Est.

$-0.12

Q4'23

Missed

by $0.02

The last earnings report on November 12 showed earnings per share of -60 cents, missing the estimate of -10 cents. With 1.03M shares outstanding, the current market capitalization sits at 296.87M.

View a ticker or compare two or three

Compare

CRVS